properties of a material. It is used to determine the crystalline forms in a mixture, the amount of amorphous phase in the sample, and examine phase transitions. It is widely used in pharmacy in the field of drug design, drug or quality control or identification of counterfeit drugs (11) (12) (13) (14) (15) .
Raman spectroscopy is a quick, safe analytical method based on inelastic scattering of monochromatic light. It is widely used in qualitative analysis, determination of molecular bonds, crystallinity, polymorphic forms, uniformity of blended substances, purity, contamination (16) (17) (18) (19) (20) . It is used for organic and inorganic compounds, for gases, liquids, and solid forms. In contrast to IR spectroscopy, the Raman spectrum may also be used for the identification of APIs in the presence of water.
Fourier Transform-Infrared Spectroscopy (FT-IR) is also a fast, non-destructive analytical technique to identify solid, liquid, and gas materials. The technique, however, requires special preparation of samples for testing. In the literature, we have found numerous examples of the use of FT-IR in identifying APIs in both crystalline and amorphous forms (21) (22) (23) .
In the study, paracetamol was chosen as the model substance. Paracetamol (acetaminophen) is one of the most popular analgesics and antipyretic drugs, although it does not reduce tissue inflammation. It is used worldwide as a fast over the counter pain reliever, which is considered to possess high efficacy and generally rare side effects. The routes of its administration are oral, rectal, buccal and intravenous. Paracetamol is assigned to the I group in Biopharmaceutics Classification System (BCS) as a highly soluble and highly permeable substance. It exists in three polymorphic forms (24, 25) . The first monoclinic form I is the most stable and the most common commercially used form (26) . The melting point is in the range of 167-169 O C. The orthorhombic form II is metastable and has a melting point at 156 O C. The third polymorph ñ form III is unstable under normal conditions and can be stabilized between microscope slides, glass capillaries, or cover glass (25) (26) (27) . By modifying the reheating cycle of form I, it can transform into the form III or II. What is more, the III form might change into a form I or II depending on the preparation process (28) . The majority absorption of acetaminophen takes place at the beginning of the small intestine after oral administration. It is a passive process that might happen in two directions: diffusion through epithelial, endothelial cells, and paracellular transport. A rate-determining step of the absorption is the gastric emptying into the small intestine (29) .
Considering the possible influence of changing the crystalline form of APIs on its solubility, it is important to monitor changes in the crystalline forms of paracetamol during the preparation of pharmaceutical dosage forms. The correlation between the change in the crystal structure of APIs and the changes in its solubility is particularly significant to determine when the substance is assigned to the IV class in BCS or if API is present in multiple formulations or when the bioavailability of API depends primarily on the dynamics of its distribution through biological membranes.
Bearing in mind the need to control the structural changes of APIs, we need to appropriate analytical methods to monitor possible structural conversions. Therefore, this study aimed to answer which of the spectroscopic techniques (FT-IR or Raman spectroscopy) is more suitable for monitoring structural changes of paracetamol while PXRD was used as the reference technique.
EXPERIMENTAL

Materials
The commercially available samples of paracetamol (P1, P2) were kindly provided by PozLab Ltd. Center of Research and Development (Poland).
Characterization of polymorphic forms of paracetamol
The identification of polymorphic forms of API was performed via X-ray powder diffraction studies (PXRD), FT-IR spectroscopy and Raman spectroscopy coupled with DFT calculations as support methods.
X-ray powder diffraction (PXRD)
The identification of polymorphic forms of paracetamol in samples P1 and P2 was carried out via X-ray powder diffraction (PXRD) and compared to reference data obtained from the Cambridge Structural Database System ñ CSD System (30) comprising ConQuest (31) and Mercury (32) . The samples were grounded for 15 min in a Retsch MM400 mixer mill operating at 15 Hz and placed in sample rings with specimen well ∅ 25 mm x 1 mm. The diffraction patterns were recorded on a Bruker AXS D2 Phaser diffractometer with LynxEye XE-T 1-dim detector using Cu Kα radiation (λ = 1.54060 Å). The operating voltage and current were maintained at 30 kV and 10 mA, respectively. The measurements were carried out at the scanning range 2θ between 5 O to 60 O using a step size of 0.02 O , with a counting rate of 2s/step. The acquired data were ana-lyzed using the DIFFRAC.EVA (33) program and KDif (Kalvados Software) (34) .
Raman spectroscopy
Raman spectra of paracetamol and were obtained with a LabRAM HR800 spectrometer (HORIBA Jobin Yvon) with the laser (HeñNe) excitation λ exc = 633 nm. Raman spectra in the range 100-3600 cm -1 .
FT-IR spectroscopy
Spectra of paracetamol were recorded after preparing pellets with IR grade KBr in the hydraulic press. All samples were measured in a frequency range of 400-4000 cm -1 with an FT-IR Bruker Equinox 55 spectrometer equipped with a Bruker Hyperion 1000 microscope.
Theoretical study
The analysis of changes in the experimental spectra of acetaminophen was conducted basing on the theoretical spectra. All the calculations were performed using the Gaussian 09 package (35) . The initial geometries were set equal to the crystal structures obtained from the Cambridge Crystallographic Data Centre. The geometry was optimized using Density Functional Theory with Becke, threeparameter, Lee-Yang-Parr hybrid functional, and 6-311+ G (3 d, p) basis set (36, 37) .
RESULTS AND DISCUSSION
Powder diffraction studies (PXRD) were performed to identify the polymorphic forms of paracetamol in the P1 and P2 samples (Figure 1 ). Comparison of P1 and P2 diffractograms with those obtained from CSD Database for paracetamol form I and II revealed that two experimental PXRD patterns agree well with the peaks characteristic for a monoclinic form of paracetamol ( Figure 1 ). However, in the P1 sample, there are three extra intensities at the Bragg 2θ angles of 10.9 O , 21.1 O and 21.9 O which are not present in the reference diffractogram of form I of paracetamol. One of these additional peaks matches the diffractogram of orthorhombic form II of paracetamol (21.9 O ). Nevertheless, the lack of intense peaks of form II paracetamol (17.5 O or 19.2 O ) in the diffractogram of the P1 suggests the contamination of the sample rather than the presence of form II of paracetamol. A comparison of P1 and P2 diffraction patterns shows that the P2 contains fewer impurities than P1.
As the alternative methods for the identification of polymorphic forms of acetaminophen in P1 and P2 samples, there were performed FT-IR and Raman spectra. The interpretation of characteristic bands of spectra was supported by theoretically calculated spectra (Figures 2-5 ). Good agreement of in sillico and experimental spectra allowed to identify the vibrational bands on the experimental spectrum which may be indicative for polymorphic forms determination. Infrared FT-IR spectra have specific bands according to the monoclinic form of paracetamol (38) . There are strong and accurately separated bands at 1441, 1505, 1564, 1610 and 1654 cm -1 ( Table 1 ). The first one is associated with C=O stretching vibrations. Moreover, there are characteristic bands for the monoclinic form of paracetamol according to the amide region of the particle. For an instant, there is a 1227 cm -1 band related to C-N and C-C stretching vibrations, 1244 cm -1 associated with C-N-H bending vibrations, 1260 cm -1 responsible also for C-N-H bending vibrations and additionally connected to C-O stretching vibrations and C-C-H bending vibrations of the aryl group. Paracetamol in monoclinic form is characterized by absorption bands in wavelength of 806 and 837 cm -1 responding to bending vibrations of the phenyl group, and what is more, by absorption bands in 2500-3500 cm -1 region, for example, there are peaks at 3327 and 3162 cm -1 related to N-H and O-H stretching vibrations. Another confirmation for the monoclinic form of paracetamol is lack of absorption peaks at 1666, 1623, 1558, 1454, 1220, 710, 608, 531 and 508 cm -1 which are characteristic for orthorhombic form (39) . Figures 4 and 5 , the Raman spectra of both samples are different. The Raman spectrum of the P2 sample contains characteristic bands for a monoclinic form of paracetamol for instance peaks at 1648, 1612, 1325, 1237 and 859 cm -1 . The first band is related to C=O stretching vibrations, the second one is associated with C-N, C-O, C-C stretching vibrations of the aryl group. The peak 1327 cm -1 is related to C-O-H bending vibrations, C-H rocking vibrations and C-C stretching vibrations of the aryl group. The last peaks are related to C-N and C-C stretching vibrations of amide group and breathing of the phenyl group. At the spectrum there are also medium intensive bands: 1562 cm -1 is related to C-N-H in plane bending vibrations, 1372 cm -1 associated with wagging of CH3, 1168 cm -1 responding to C-O-H and C-C-H bending vibrations of the aryl group. The peaks at 799 and 653 cm -1 are associated with C-N-C bending vibrations and deformations of phenyl group. The peak 466 cm -1 associated with deformation of the aryl group is also characteristic for the monoclinic form of acetaminophen. The bands at 169, 385, 688, 1093, 1182, 1285,1431 and 1608 cm -1 donít exist for monoclinic form, it leads to the conclusion that the sample P1 is an orthorhombic form of paracetamol. The first three peaks are related to respectively bending in plane and out of plane the structure of acetaminophen, deformation of aryl group and C-C stretching vibrations of amide group and also C-H twisting vibrations. The fourth band responds to C-H rocking vibrations of the amide group. The peak at 1093 cm -1 is associated with C-O-H and C-C-H bonds bending. The fifth band is related to C-O-H, C-C-H bending vibrations, and C-N stretching vibrations. The last two peaks are associated with respectively C-O-H, C-N-H bending vibrations and C-C, C-N, C-O stretching vibrations. There are many other bands related to vibrations of the same bonds for both polymorphic forms of paracetamol, there are also additive peaks that appear or disappear depending on which polymorphic form is present in the sample ( Table 1) . As presented above, accurate analysis of FT-IR spectra of structurally different paracetamol samples did not show the possibility of distinguishing them. Moreover, the use of the reference technique ñ PXRD confirmed the presence only of the monoclinic form of paracetamol in the tested samples. The second of the used techniques ñ Raman spectroscopy, confirmed that both samples of paracetamol P1 and P2 contain a monoclinic form of paracetamol. However, it proved the presence of impurities in the sample P1 of paracetamol, described as the second polymorphic form ñ orthorhombic. In relation to the above, we can suggest that the PXRD and Raman techniques are more sensitive than FT-IR in detecting impurities in the compounds and Raman spectroscopy is essential in both defining the polymorphic structure and identifying impurities of compounds in the case of paracetamol.
As shown in
CONCLUSIONS
For identification of polymorphic forms of paracetamol X-ray powder diffraction approach is a suitable technique that can be recommended as a reference method. As alternative methods, FT-IR and Raman spectroscopy were studied. In accordance with the results obtained from the PXRD technique, it can be pointed out that Raman spectroscopy is a technique that confirmed the presence of impurities in paracetamol samples. Thus, it is possible to suggest that Raman spectroscopy is a more sensitive technique than FT-IR with regard to the identification of selected polymorphic forms and the purity of paracetamol in the test samples.
